Wrana, 1998; Kretzschmar and Massagué , 1998). Thus, been defined: the receptor-regulated Smads, which into define additional components of this pathway, we clude Smad1, 2, 3, 5, and 8; the common mediator Smad, initiated a screen to identify Smad2 partners. For this, Smad4; and the antagonistic Smads, which include the MH2 domain of Smad2 was fused to glutathione-SSmad6 and 7 (Heldin et al., 1997; Attisano and Wrana, transferase (GST) that included a kinase recognition site 1998; Kretzschmar and Massagué , 1998 ). Receptor-regfor protein kinase A (PKA). The bacterially expressed ulated Smads (R-Smads) act as direct substrates of fusion protein was labeled to high specific activity using PKA (Chen and Sudol, 1995) and then used to screen a ZAPII expression library prepared from the dorsal § To whom correspondence should be addressed (e-mail: jwrana@ sickkids.on.ca).
blastopore lip of Xenopus. This yielded repeated isolates of a partial cDNA clone. To obtain the entire coding protein of 1235 amino acids with an estimated molecular mass of 135 kDa ( Figure 1A ). Based on our subsequent sequence, we probed the blastopore lip library with the partial cDNA clone and performed 5Ј RACE. Analysis functional analysis, we have called this cDNA XSARA, for Xenopus Smad anchor for receptor activation. of the complete cDNA sequence revealed a predicted To investigate the role of this protein in TGF␤ signaling in mammalian cells, we identified a human homolog using a combination of degenerate RT-PCR and screening of a human brain cDNA library. Analysis of the contiguous sequence revealed a long open reading frame that encoded a predicted protein of 1323 amino acids with a consensus start codon preceded by stop codons in all three reading frames. Comparison of this sequence with that from XSARA ( Figure 1A ) revealed an overall identity of 62% with a divergent 558-residue amino terminal domain (35% identity) followed by a closely related carboxy-terminal domain (85% identity). Given this sequence similarity and subsequent functional analysis, we designate this clone hSARA, for human SARA.
Sequence analysis of SARA ( Figure 1A ) revealed a region in the middle portion of the predicted protein that had similarity to a double zinc finger domain or FYVE domain. The FYVE domain has been identified in a number of unrelated signaling molecules that include FGD1, a putative guanine exchange factor for Rho/Rac that is mutated in faciogenital dysplasia; the HGF receptor substrate Hrs-1 and its homolog, Hrs-2; EEA1, a protein involved in formation of the early endosome; and the yeast proteins FAB1, VPS27, and VAC1 (reviewed in Wiedemann and Cockcroft, 1998 Figure 1B) . Thus, SARA contains a FYVE domain that may function to bind PtdIns(3)P.
Analysis of the expression pattern of hSARA revealed that the gene was expressed in all adult tissues examined, similar to Smad2 (Figure 2A ). Further analysis in a variety of cell lines by RT-PCR revealed that SARA was expressed in every cell line tested, including HepG2 We also tested for interaction between endogenous SARA and Smad2. For this, SARA was immunoprecipitated from HepG2 cells using an affinity-purified anti-SARA polyclonal antibody, and Smad2 was visualized by immunoblotting with anti-Smad2 antibody (Macías-Silva et al., 1998). In immunoprecipitates prepared with preimmune antisera, no Smad2 was detectable ( Figure  2D ). However, in the anti-SARA immunoprecipitates, we could clearly detect Smad2 coprecipitating with SARA. Interestingly, TGF␤ treatment prior to lysis revealed decreased association of Smad2 with SARA. Together, these results demonstrate that SARA is a specific partner for receptor-regulated Smads in the TGF␤/activin , 1996) . These data suggest that SARA associates with the TGF␤ to common subcellular domains.
Since SARA and TGF␤ receptors colocalize, we tested receptor.
We next examined whether coexpression of Smad2 might enhance the interaction of SARA with TGF␤ receptors. In cells expressing wild-type receptor I, we observed no difference in the amount of receptor complexes that coprecipitated with SARA either in the presence or absence of Smad2 ( Figure 5B, compare lanes 3 and  5) . In contrast, the association of SARA with receptor complexes containing kinase-deficient type I receptors was enhanced by Smad2 ( Figure 5B, lane 4) . This finding was consistent with our previous demonstration that kinase-deficient type I receptors stabilize interactions of Smad2 with the receptors (Macías-Silva et al., 1996) . To investigate further the requirement for Smad2 in the interaction of SARA with the receptor, we also tested a mutant of SARA, SARA(⌬SBD), that removes the Smadbinding domain (see below). Analysis of SARA interaction with receptor complexes containing kinase-deficient T␤RI showed that wild-type SARA interacted with the receptor, and this was enhanced approximately 2-fold by Smad2 ( Figure 5C ). The ⌬SBD mutant of SARA retained the capacity to associate with the receptor, although the efficiency of interaction was slightly reduced relative to wild-type SARA. Importantly, unlike wild-type SARA, binding of mutant SARA to the receptor was not enhanced by coexpression of Smad2. Together, these data suggest that SARA interacts with the TGF␤ receptor independently of Smad2 binding and that Smad2 cooperates to enhance association.
A Modular Domain in SARA Mediates Association with Smads
To investigate the functional importance of SARA in TGF␤ signaling, we defined the domains in the protein that mediate its interaction with Smad2, its localization to specific subcellular regions, and its association with the TGF␤ receptor. To this end, we constructed a series of deletion mutants of SARA and first tested their ability to interact with Smad2 in COS cells by immunoprecipitation followed by immunoblotting. As summarized in Figure 6A, we did not observe complete colocalization with SARA. Together, these results suggest a model ( Figure 7E) in However, once signaling has commenced, Smad2 diswhich SARA is localized to specific subcellular regions sociates from SARA, binds to Smad4, and translocates in the cell through interactions between the FYVE doto the nucleus, freeing SARA to recruit additional Smad2 main and PtdIns ( 
